| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.33 | 0.02 |